United States

Analyst Research Report Snapshot


Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review






07 Jan 2013





Companies referenced:


Available for Immediate Download

Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review Summary Bristol-Myers Squibb Company (BMS) is is global biopharmaceutical company. It undertakes the discovery, development, licensing, manufacture, marketing and distribution of biopharmaceuticals and related healthcare products. Its principal areas of focus include cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/AIDS and rheumatoid arthritis. The company operates through a single reportable business segment, Biopharmaceuticals. Bristol-Myers Squibb Company Key Recent Developments: Jan 04, 2013: Tranzyme Pharma Announces Successful Completion Of Drug Discovery Collaboration With Bristol-Myers Squibb Dec 14, 2012: Bristol-Myers Squibb Joins Multiple Myeloma Research Foundation To Advance Personalized Medicine Approaches For Multiple Myeloma Nov 06, 2012: Bristol-Myers Squibb Eliminates 479 Sales And Marketing Jobs Oct 24, 2012: Bristol-Myers Squibb Reports Revenue Of $3.7 Billion In Q3 2012 Oct 16, 2012: Bristol-Myers Squibb Announces Presentation Of 27 Abstracts On Company's Research In Liver Diseases At AASLD 2012 This comprehensive SWOT profile of Bristol-Myers Squibb Company provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description - A detailed description of the company's operations and business divisions. - Corporate strategy - Analyst's summarization of the company's business strategy. - SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats. - Company history - Progression of key events associated with the company. - Major products and services - A list of major products, services and brands of the company. - Key competitors - A list of key competitors to the company. - Key employees - A list of the key executives of the company. - Executive biographies - A brief summary of the executives' employment history. - Key operational heads - A list of personnel heading key departments/functions. - Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities - A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Note: Some sections may be missing if data is unavailable for the company. Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors' business st...

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.